Lemaitre Vascular (LMAT) Share-based Compensation (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Share-based Compensation data on file, last reported at $2.1 million in Q1 2026.

• Share-based Compensation for Q1 2026 came in at $2.1 million, up 2.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (up 12.39% YoY), and the FY2025 annual result was $7.8 million, up 19.15% from the prior year.
• Share-based Compensation was little changed at $2.1 million in Q1 2026 per LMAT's latest filing, from $2.1 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $2.1 million in Q4 2025 and troughed at $684000.0 in Q4 2022.
• A 5-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation fell 22.8% in 2022, then soared 105.26% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $684000.0 in 2022, then soared by 105.26% to $1.4 million in 2023, then rose by 23.86% to $1.7 million in 2024, then rose by 20.53% to $2.1 million in 2025, then fell by 0.19% to $2.1 million in 2026.
• Business Quant data shows LMAT's Share-based Compensation at $2.1 million in Q1 2026, $2.1 million in Q4 2025, and $1.7 million in Q3 2025.